SMAD2 and liver cancer: It can be seen from the data in Figure 4 that propofol can effectively increase the activity of the TGF-β1/Smad2 signaling pathway, resulting in a significant reduction in the proliferation of liver cancer cells, and the tumor inhibition rate can reach 35%.